Cell Surface Markers Market is predicted to rise in coming years (2018-2023)

The cell surface markers market was estimated to be worth USD 520 million in 2018 and is expected to grow at an annual rate of 8.1 percent to USD 769 million by 2023. The market is predicted to rise in the coming years due to factors such as increased financing for life sciences research, a high global prevalence of cancer, and expansion in stem cell and neurobiology research.


In the future years, the demand for mice as a source of antibodies is expected to rise.

The global cell surface markers market is divided into mice, rats, and other sources based on antibody sources. The mice segment is predicted to hold the highest share of the cell surface markers market in 2018. This category is also predicted to increase at the fastest CAGR during the forecast period, owing to the cost-effectiveness of mice models as a source of antibody production.

During the projected period, the T cell surface markers segment will lead the cell surface markers market by cell type.

T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types make up the cell surface markers market. T cell surface markers are predicted to command the highest proportion of the cell surface markers market in 2018. The use of these cell surface markers in research and diagnosis is expected to fuel the growth of this segment.

In 2018, the research applications segment is expected to lead the cell surface markers market by application.

The cell surface markers market is divided into two categories based on application: research and clinical. The cell surface markers market is estimated to be dominated by the research applications segment in 2018. The increased public-private support for cell surface marker-based research, as well as the growing usage of cell surface markers in cancer, stem cell, and HIV research, are responsible for the substantial share of this segment.

The major end consumers of cell surface markers in 2018 are expected to be academic and research institutes.

Academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology businesses are the different types of end users in the cell surface markers market. Academic and research institutes are likely to dominate the cell surface markers market in 2018.The increasing use of cell surface markers in cancer, stem cell, and HIV research, as well as the expanding public-private funding for cell surface marker-based research, are driving the expansion of this end-user category.

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market